Despite improvements, large observational studies such as the Dialysis Outcomes and Practice Patterns Study (DOPPS) indicate that anemia remains prevalent in patients receiving dialysis; therefore, there is a need to increase the proportions of patients achieving guideline Hb targets [21]. This evidence concerns the gene GSTM1 and anemia (phenotype).